Delivery Order SPE2DB22D2211-SPE2DB25FSFSW
- Not listed
- The Defense Logistics Agency awarded a $32,008.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 500 tablets of Topiramate 25 mg on September 5, 2025, with an ultimate completion date of September 8, 2025. This delivery order was issued without a set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. Topiramate is an anticonvulsant medication commonly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of 500 tablets of Topiramate 25 mg at a ceiling value of $8,738.79. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The contract is set for completion by September 15, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Topiramate 50 mg tablets in quantities of 1,000 units. This is a firm fixed-price delivery order with a ceiling value of $1,093.14 and an ultimate completion date of September 22, 2025. The contract carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania—the same location...
- The Defense Logistics Agency awarded a delivery order valued at $1,005.03 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Topiramate 100 mg. This contract, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,823.80 for 500 tablets of Topiramate 25 mg under a firm fixed price contract. The award was made on July 14, 2025, with an ultimate completion date of July 15, 2025, and represents a non-competitive delivery order issued without set-aside designation. Performance will be executed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,032.61 to AmerisourceBergen Drug Corp for 500 tablets of Topiramate 25 mg. The contract, which became effective on August 18, 2025, with an ultimate completion date of August 19, 2025, utilizes firm fixed price pricing and was awarded without a set-aside designation. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Topiramate 25 mg tablets in quantities of 500 units, with a contract ceiling value of $7,555.16. This is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, and represents a non-set-aside competitive award. The delivery location is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Topiramate 50 mg tablets in quantities of 1,000 units, with a contract ceiling value of $2,278.74 and an ultimate completion date of August 20, 2025. This is a firm fixed price, non-set-aside delivery order executed under a competitive procurement process. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $5,076.43 to AmerisourceBergen Drug Corp for 500 tablets of Topiramate 25 mg, with an ultimate completion date of August 28, 2025. This competitive award, executed on August 27, 2025, utilizes firm fixed pricing and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Topiramate 50 mg tablets (1,000 count) with a ceiling value of $1,317.00. This firm fixed-price delivery order, which must be completed by September 2, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract carries no set-aside designation, indicating it was competitively awarded through open procurement channels. This...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSFSWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for 1,000 tablets of Topiramate 100 mg at a firm fixed price of $1,566.48. The award is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 24, 2025. Topiramate is a commonly prescribed anticonvulsant and migraine prevention medication, indicating this delivery order supports pharmaceutical supply needs within the federal medical supply chain, likely for military or Department of Defense healthcare systems. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates consistent performance in delivering pharmaceutical products through competitively awarded, firm fixed-price arrangements ranging from small-value transactions to substantial orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/23/25 |